Determinants of Tacrolimus Interpatient Variability in Renal Transplantation: A Comprehensive Pharmacogenomic and Clinical Review
Tacrolimus is a cornerstone immunosuppressive agent widely used in renal transplantation to prevent graft rejection. Its therapeutic application is challenged by a narrow therapeutic index and substantial interpatient variability in pharmacokinetics and pharmacodynamics. This variability can result in subtherapeutic exposure leading to acute rejection or supratherapeutic levels associated with nephrotoxicity and other adverse effects. The present review provides a comprehensive and critically synthesized evaluation of the determinants contributing to tacrolimus interpatient variability among kidney transplant recipients. Particular emphasis is placed on pharmacogenomic factors, especially polymorphisms in CYP3A5, which significantly influence tacrolimus metabolism and dose requirements. Additionally, drug transporters such as ABCB1 and other genetic variants are explored for their contributory roles. This review shows the impact of drug-drug interactions, formulation variability, adherence patterns, and environmental factors such as diet and lifestyle and importance of therapeutic drug monitoring in mitigating variability and improving clinical outcomes is emphasized. Emerging precision medicine approaches integrating pharmacogenomics with clinical decision-making are critically examined. This review underscores the necessity of a multifactorial and individualized approach to tacrolimus dosing. By integrating genetic, clinical, and environmental determinants, clinicians can enhance therapeutic efficacy, minimize toxicity, and improve long-term graft survival. Future perspectives include the incorporation of artificial intelligence and predictive modeling to optimize personalized immunosuppressive therapy.
Authors
- Shaiju S Dharan (ORCID: https://orcid.org/0000-0002-8539-1789)
- Grace N. Raju
- Iswarya Chandran
Publication Details
- Journal
- Zenodo (CERN European Organization for Nuclear Research)
- Published
- 2026-11-21
- DOI
- https://doi.org/10.5281/zenodo.24424408
- Primary Topic
- Renal Transplantation Outcomes and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00